AbstractHeart failure is a major health problem with an increasing incidence and prevalence of the disease. The role of both established natriuretic peptides: B-type natriuretic peptide (BNP) and N-terminal prohormone pro-brain natriuretic peptide (NT-proBNP) in acute and chronic heart failure (HF) has been intensively studied. Its testing is routine in clinical practice for diagnosis and prognosis in HF. However, increased clarification and understanding of the interplay in the pathophysiology of HF revealed several new potential cardiac biomarkers. These novel biomarkers soluble ST2, galectin, copeptin and, mid-regional fragment of pro-adrenomedullin (MR-proADM) may aid in the diagnostic and prognostic evaluation of acute and chronic hear...
ObjectivesThis study sought to explore the role of new biomarkers in heart failure (HF).BackgroundWe...
Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed....
SummaryThe care of patients with heart failure can be challenging, with few objective tools availabl...
AbstractHeart failure (HF) biomarkers have dramatically impacted the way HF patients are evaluated a...
AbstractHeart failure is a major health problem with an increasing incidence and prevalence of the d...
Heart failure (HF) is a significant cause of morbidity and mortality worldwide. Circulating biomarke...
The role of biomarkers is increasingly recognized in heart failure (HF) management, for diagnosis, p...
BACKGROUND AND PURPOSE: Natriuretic peptides have led the way as a diagnostic and prognostic tool fo...
Aims: To test the prognostic value of emerging biomarkers in the Reduction of Events by Darbepoe...
Heart failure (HF) is the final common pathway of many cardiovascular diseases and is associated wit...
Department of Biochemistry and Clinical Biochemistry, Nicolae Testemitanu State University of Medic...
Tremendous advances have been made in understanding the pathophysiology and treatment of congestive...
New biomarkers are being evaluated for their ability to advance the management of patients with hear...
ObjectivesThis study sought to explore the role of new biomarkers in heart failure (HF).BackgroundWe...
Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed....
SummaryThe care of patients with heart failure can be challenging, with few objective tools availabl...
AbstractHeart failure (HF) biomarkers have dramatically impacted the way HF patients are evaluated a...
AbstractHeart failure is a major health problem with an increasing incidence and prevalence of the d...
Heart failure (HF) is a significant cause of morbidity and mortality worldwide. Circulating biomarke...
The role of biomarkers is increasingly recognized in heart failure (HF) management, for diagnosis, p...
BACKGROUND AND PURPOSE: Natriuretic peptides have led the way as a diagnostic and prognostic tool fo...
Aims: To test the prognostic value of emerging biomarkers in the Reduction of Events by Darbepoe...
Heart failure (HF) is the final common pathway of many cardiovascular diseases and is associated wit...
Department of Biochemistry and Clinical Biochemistry, Nicolae Testemitanu State University of Medic...
Tremendous advances have been made in understanding the pathophysiology and treatment of congestive...
New biomarkers are being evaluated for their ability to advance the management of patients with hear...
ObjectivesThis study sought to explore the role of new biomarkers in heart failure (HF).BackgroundWe...
Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed....
SummaryThe care of patients with heart failure can be challenging, with few objective tools availabl...